bordetella pertussis filamentous hemagglutinin
SpainDrugs containing this active substance
-
This vaccine is used for booster vaccination in children aged 3 years and older, adolescents, and adults to prevent four diseases: diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage bordetella pertussis toxoid 8 UG bordetella pertussis filamentous hemagglutinin 8 UG bordetella pertussis pertactin 2,5 UG poliovirus type i 40 U.D. (UNIDADES ANTIGENICAS D) poliovirus type ii 8 U.D. (UNIDADES ANTIGENICAS D) poliovirus type iii 32 U.D. (UNIDADES ANTIGENICAS D) diphtheria toxoid 2,5 Lf tetanus toxoid 5 Lf Manufacturer: Glaxosmithkline S.A.
-
It is used as a booster vaccine to prevent three diseases: diphtheria, tetanus (lockjaw), and pertussis (whooping cough) in children aged 4 years and older, adolescents, and adults.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage diphtheria toxoid 2 UI bordetella pertussis 69 kd outer membrane protein 2,5 µg bordetella pertussis filamentous hemagglutinin 8 µg bordetella pertussis toxoid 8 µg tetanus toxoid 20 UI Manufacturer: Glaxosmithkline S.A.
-
It is a vaccine that helps protect children from six weeks of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection
Active substance Dosage diphtheria toxoid 20 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg haemophilus influenzae type b capsular polysaccharide prp 12 µg Manufacturer: Sanofi Winthrop Industrie
-
It is a vaccine that helps protect children from six weeks of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg h. influenzae type b polysaccharide tetanus toxoid conjugate 12 µg diphtheria toxoid 20 UI Manufacturer: Sanofi Winthrop Industrie
-
It is a vaccine that helps protect children from six weeks of age against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection
Active substance Dosage diphtheria toxoid 20 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg haemophilus influenzae type b capsular polysaccharide prp 12 µg Manufacturer: Sanofi Winthrop Industrie
-
This vaccine is used to protect children against six diseases: diphtheria, tetanus, pertussis, hepatitis B, polio, and Haemophilus influenzae type b (Hib) infection.
Form: powder and solvent for injectable suspension
Active substance Dosage diphtheria toxoid 30 UI tetanus toxoid 40 UI h. influenzae type b polysaccharide tetanus toxoid conjugate 0,02 mg haemophilus influenzae type b 0,01 mg bordetella pertussis toxoid 0,025 mg bordetella pertussis filamentous hemagglutinin 0,025 mg bordetella pertussis 69 kd outer membrane protein 0,01 mg poliovirus type i 40 U.D. (UNIDADES ANTIGENICAS D) poliovirus type ii 8 U.D. (UNIDADES ANTIGENICAS D) poliovirus type iii 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 0,01 mg Manufacturer: Glaxosmithkline Biologicals
-
This vaccine is used to protect children against six diseases: diphtheria, tetanus, pertussis, hepatitis B, polio, and Haemophilus influenzae type b (Hib) infection.
Form: powder and solvent for injectable suspension
Active substance Dosage diphtheria toxoid 30 UI tetanus toxoid 40 UI h. influenzae type b polysaccharide tetanus toxoid conjugate 20 µg haemophilus influenzae type b 10 µg bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg bordetella pertussis 69 kd outer membrane protein 10 µg poliovirus type i 40 U.D. (UNIDADES ANTIGENICAS D) poliovirus type ii 8 U.D. (UNIDADES ANTIGENICAS D) poliovirus type iii 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg Manufacturer: Glaxosmithkline Biologicals
-
It is used as a booster dose to protect children against four diseases: diphtheria, tetanus, pertussis (whooping cough), and polio.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage diphtheria toxoid 30 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg bordetella pertussis pertactin 8 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) Manufacturer: Glaxosmithkline S.A.
-
It is a vaccine that helps protect children against diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage diphtheria toxoid 20 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) Manufacturer: Sanofi Winthrop Industrie
-
This vaccine is used as a booster to protect against diphtheria, tetanus, and pertussis (whooping cough) in children aged four and older, adolescents, and adults who have already completed their initial vaccination schedule. In pregnant women, it helps transfer protection against pertussis to the baby during their first months of life.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage diphtheria toxoid 2 UI tetanus toxoid 20 UI bordetella pertussis toxoid 2,5 µg bordetella pertussis filamentous hemagglutinin 5 µg bordetella pertussis pertactin 3 µg pertussis fimbriae agglutinogen toxoid 5 µg Manufacturer: Sanofi Winthrop Industrie
-
This vaccine helps protect children against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage diphtheria toxoid Mayor o igual a 20 UI tetanus toxoid Mayor o igual a 40 UI bordetella pertussis toxoid 20 µg bordetella pertussis filamentous hemagglutinin 20 µg bordetella pertussis pertactin 3 µg pertussis fimbriae agglutinogen toxoid 5 µg inactivated poliovirus type 1 mahoney produced in vero cells 29 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 7 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 26 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg conjugate haemophilus influenzae prp-neisseria meningitidis ompc 3 µg Manufacturer: Mcm Vaccine B.V.